A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

NCT04162015 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma

Interventions

DRUG: Nivolumab
DRUG: Pemetrexed
DRUG: Cisplatin or Carboplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]